Skip to main content
Caplight Logo









WaveBreak Therapeutics

WaveBreak Therapeutics

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://wavebreaktx.com/

Last Round

VC Round

Jan 25, 2021

Total Funding Raised

$23M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

WaveBreak Therapeutics is a biotechnology company that develops a platform of therapeutics to target protein-misfolding diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

small molecule therapeuticsneurodegenerative diseasedrug discovery platformprotein aggregationbiophysics drug discoverybiopharmaoligomer targetingParkinson's diseaseAlzheimer's diseaseALS treatmentundruggable targetsclinical stage biotechpharma licensingLewy body dementiaTDP-43

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

WaveBreak Therapeutics Comparables

Compare WaveBreak Therapeutics with similar companies based on industry and business-model similarity.

WaveBreak Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Treventis Corporation
87%
Gismo Therapeutics
84%
MODAG
81%

WaveBreak Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 25, 2021
Series AJan 22, 2019

Key People

Founding team and executive leadership

Bart Henderson

Chief Executive Officer, President

Executive Team

WaveBreak Therapeutics Investors

Notable investors and investment history

WaveBreak Therapeutics investors
InvestorRounds
Lifeforce CapitalSeries A, VC Round
Schooner CapitalVC Round
Industry VenturesVC Round
The Baupost GroupSeries A, VC Round
Malin PLCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 321% MoM, reaching 2K.

  • Jun 18, 2026

    Monthly visitors increased 160% MoM.

WaveBreak Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

WaveBreak Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about WaveBreak Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range7
Year Founded2016
Last FundingJan 25, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?